GSK's ViiV Healthcare has suspended development of a Phase 2-stage HIV antiviral named VH3739937, a GSK spokesperson ...

A New York federal judge has denied Amgen’s motion to dismiss a class action lawsuit alleging the company misled investors ...

Senators may be back in their districts gearing up for next month's elections, but that isn't stopping them from questioning ...

Enliven Therapeutics released new Phase 1 data for its chronic myeloid leukemia program (CML) it hopes can eventually compete ...

Shattuck Labs is laying off 40% of its workforce and discontinuing its CD47 program in acute myeloid leukemia and higher-risk ...

Months after announcing the failure of a mid-stage trial for its personalized neoantigen vaccine in cancer, Gritstone bio ...

Struggling healthcare giant CVS Health is considering breaking up the company, including separating its pharmacy and ...

Obesity startup Metsera is getting a new manufacturing partner and a new CEO. On Tuesday, the well-funded startup announced ...

IGM Biosciences will stop working in cancer and shrink its T cell engager pipeline to focus on autoimmune diseases, the ...

Plus, news about IN8bio, Sanofi, Vicore Pharma, Cartherics, Zephyrm Bioscience, Tharimmune and Intract Pharma: Biohaven’s $250M offering: The move comes after Biohaven announced Monday that it started ...

There's major money behind efforts to speed the next significant obesity company to the market. First, it was Metsera, which ...

A New York federal judge dismissed allegations on Monday that Bristol Myers Squibb purposely delayed Breyanzi’s approval to ...